Bemnifosbuvir-Ruzasvir (BEM/RZR)
AT-01B-007
Phase 3 small_molecule active
Quick answer
Bemnifosbuvir-Ruzasvir (BEM/RZR) for HEPATITIS C VIRUS CHRONIC INFECTION is a Phase 3 program (small_molecule) at Atea Pharmaceuticals with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Atea Pharmaceuticals
- Indication
- HEPATITIS C VIRUS CHRONIC INFECTION
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- active